Search Results

You are looking at 1 - 10 of 52 items for :

  • "platelet-rich plasma" x
Clear All
Thomas Collins Trauma & Orthopaedics, Wythenshawe Hospital, Wythenshawe, UK

Search for other papers by Thomas Collins in
Google Scholar
PubMed
Close
,
Dinesh Alexander Trauma & Orthopaedics, Salford Royal Hospital, Salford, UK

Search for other papers by Dinesh Alexander in
Google Scholar
PubMed
Close
, and
Bilal Barkatali Trauma & Orthopaedics, Salford Royal Hospital, Salford, UK

Search for other papers by Bilal Barkatali in
Google Scholar
PubMed
Close

performed using the Medline, EMBASE and Cochrane Reviews databases for all papers published between 1978 and 2019 containing the following key terms: “platelet-rich plasma” AND “orthopaedics” AND (“classification” OR “mechanism of action” OR “preparation” OR

Open access
Mohammad Shahid St Michael’s Hospital, 30 Bond Street, Toronto, M5B1W8, Canada
Walsall Manor Hospital, Moat Road, Walsall, WS2 9PS, UK

Search for other papers by Mohammad Shahid in
Google Scholar
PubMed
Close
and
Rik Kundra St Michael’s Hospital, 30 Bond Street, Toronto, M5B1W8, Canada
Walsall Manor Hospital, Moat Road, Walsall, WS2 9PS, UK

Search for other papers by Rik Kundra in
Google Scholar
PubMed
Close

Introduction Platelet-rich plasma (PRP) has been used since the 1950s to manage maxillofacial and dermatological conditions. 1 , 2 The use of biological agents including PRP and mesenchymal stem cells (MSCs) in orthopaedics has increased

Open access
Alessandro Bensa Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland

Search for other papers by Alessandro Bensa in
Google Scholar
PubMed
Close
,
Alessandro Sangiorgio Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland

Search for other papers by Alessandro Sangiorgio in
Google Scholar
PubMed
Close
,
Angelo Boffa Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Search for other papers by Angelo Boffa in
Google Scholar
PubMed
Close
,
Manuela Salerno Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Search for other papers by Manuela Salerno in
Google Scholar
PubMed
Close
,
Giacomo Moraca Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland

Search for other papers by Giacomo Moraca in
Google Scholar
PubMed
Close
, and
Giuseppe Filardo Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland
Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Università della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland

Search for other papers by Giuseppe Filardo in
Google Scholar
PubMed
Close

Academy of Orthopaedic Surgeons (AAOS) ( 20 ) include intra-articular CS injections among the options to manage patients affected by knee OA. On the other side, the use of hyaluronic acid (HA) and platelet-rich plasma (PRP) for knee OA patients is more

Open access
Claudio Rosso ARTHRO Medics, Shoulder and Elbow Center, Basel, Switzerland
University of Basel, Basel, Switzerland
Swiss Orthopaedics, Grandvaux, Switzerland

Search for other papers by Claudio Rosso in
Google Scholar
PubMed
Close
,
Mark E Morrey Swiss Orthopaedics, Grandvaux, Switzerland

Search for other papers by Mark E Morrey in
Google Scholar
PubMed
Close
,
Michael O Schär Swiss Orthopaedics, Grandvaux, Switzerland

Search for other papers by Michael O Schär in
Google Scholar
PubMed
Close
,
Kushtrim Grezda ARTHRO Medics, Shoulder and Elbow Center, Basel, Switzerland
University of Basel, Basel, Switzerland
Department of Orthopedic Surgery, Division of Shoulder and Elbow, Mayo Clinic, Rochester, Minnesota

Search for other papers by Kushtrim Grezda in
Google Scholar
PubMed
Close
, and
the Swiss Orthopaedics Shoulder Elbow and Expert Group †
Search for other papers by the Swiss Orthopaedics Shoulder Elbow and Expert Group † in
Google Scholar
PubMed
Close
the Swiss Orthopaedics Shoulder Elbow and Expert Group

Introduction Platelet-rich plasma (PRP) is a platelet concentrate (PC) derived from autologous blood which contains a three to ten times higher concentration of platelets than normal peripheral blood (150 000–350 000 platelets/μL) ( 1 , 2

Open access
Hsiao-Yi Cheng Department of Primary Care Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Hsiao-Yi Cheng in
Google Scholar
PubMed
Close
,
Chun-Wei Liang School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Department of Primary Care Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan

Search for other papers by Chun-Wei Liang in
Google Scholar
PubMed
Close
,
Yu-Hao Lee Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Yu-Hao Lee in
Google Scholar
PubMed
Close
,
Timporn Vitoonpong Department of Rehabilitation, King Chulalongkorn Memorial Hospital, Bankok, Thailand

Search for other papers by Timporn Vitoonpong in
Google Scholar
PubMed
Close
,
Chun-De Liao Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
Master’s Program in Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan

Search for other papers by Chun-De Liao in
Google Scholar
PubMed
Close
, and
Shih-Wei Huang Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Shih-Wei Huang in
Google Scholar
PubMed
Close

, hyaluronic acids, platelet-rich plasma (PRP), platelet rich in growth factor (PRGF), botulinum toxin A, O 2 –O 3 , dextrose, and mesenchymal stem cell (MSC). Regarding exercise, most studies included resistance training programs to strengthen the quadriceps

Open access
Gerardo Fusco Humanitas University, Department of Biomedical Sciences, Milan, Italy
IRCCS Humanitas Research Hospital, Milan, Italy
These authors contributed equally to the article and should both be considered first authors

Search for other papers by Gerardo Fusco in
Google Scholar
PubMed
Close
,
Francesco M. Gambaro Humanitas University, Department of Biomedical Sciences, Milan, Italy
IRCCS Humanitas Research Hospital, Milan, Italy
These authors contributed equally to the article and should both be considered first authors

Search for other papers by Francesco M. Gambaro in
Google Scholar
PubMed
Close
,
Berardo Di Matteo Humanitas University, Department of Biomedical Sciences, Milan, Italy
First Moscow State Medical University – Sechenov University, Moscow, Russia

Search for other papers by Berardo Di Matteo in
Google Scholar
PubMed
Close
, and
Elizaveta Kon Humanitas University, Department of Biomedical Sciences, Milan, Italy
IRCCS Humanitas Research Hospital, Milan, Italy

Search for other papers by Elizaveta Kon in
Google Scholar
PubMed
Close

products we include corticosteroids (CS), hyaluronic acid (HA), polynucleotides, oxygen-ozone therapy, platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs). CS and HA are ranked first as the most frequently injected substances and their use is

Open access
Felix H. Savoie Tulane University, New Orleans, Louisiana, USA

Search for other papers by Felix H. Savoie in
Google Scholar
PubMed
Close
and
Michael O’Brien Tulane University, New Orleans, Louisiana, USA

Search for other papers by Michael O’Brien in
Google Scholar
PubMed
Close

months from diagnosis. Podesta et al 29 recently reported improved results using platelet-rich plasma (PRP) in a series of partial MUCL tears. In our review of a series of 25 athletes with significant injuries to the proximal or distal end of the

Open access
Luca Pierannunzii Gaetano Pini Orthopedic Institute, Milan, Italy
IRCCS Galeazzi Orthopedic Institute, Milan, Italy

Search for other papers by Luca Pierannunzii in
Google Scholar
PubMed
Close
and
Luigi Zagra Gaetano Pini Orthopedic Institute, Milan, Italy
IRCCS Galeazzi Orthopedic Institute, Milan, Italy

Search for other papers by Luigi Zagra in
Google Scholar
PubMed
Close

of large bone defects. So far, demineralised bone matrix (DBM), platelet-rich plasma (PRP), MSCs and BMPs have been tested in addition to grafts and substitutes. Demineralised bone matrix DBM is essentially the proteinaceous component of bone

Open access
Alfonso Vaquero-Picado Department of Orthopaedic Surgery, ‘La Paz’ University Hospital, Spain

Search for other papers by Alfonso Vaquero-Picado in
Google Scholar
PubMed
Close
and
E. Carlos Rodríguez-Merchán Department of Orthopaedic Surgery, ‘La Paz’ University Hospital, Spain

Search for other papers by E. Carlos Rodríguez-Merchán in
Google Scholar
PubMed
Close

, 104 However, in central tears its rate of success diminishes, probably influenced by the fact that healing in the inner third is different from the peripheral zone. 97 Platelet rich plasma Platelet rich plasma (PRP) is obtained from

Open access
Joseph J Ruzbarsky Steadman Philippon Research Institute, Vail, Colorado, USA
Steadman Clinic and United States Coalition for the Prevention of Illness and Injury in Sport, Vail, Colorado, USA

Search for other papers by Joseph J Ruzbarsky in
Google Scholar
PubMed
Close
,
Rui W Soares Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, USA

Search for other papers by Rui W Soares in
Google Scholar
PubMed
Close
,
Spencer M Comfort Steadman Philippon Research Institute, Vail, Colorado, USA

Search for other papers by Spencer M Comfort in
Google Scholar
PubMed
Close
,
Justin W Arner Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

Search for other papers by Justin W Arner in
Google Scholar
PubMed
Close
, and
Marc J Philippon Steadman Philippon Research Institute, Vail, Colorado, USA
Steadman Clinic and United States Coalition for the Prevention of Illness and Injury in Sport, Vail, Colorado, USA

Search for other papers by Marc J Philippon in
Google Scholar
PubMed
Close

platelet-rich plasma (PRP) or bone marrow aspirate concentrate (BMAC) being investigated throughout medicine and orthopedics as a source of healing ( 28 , 29 , 30 , 31 ). PRP is produced from peripheral blood by centrifugation to separate and concentrate

Open access